Impacto de la expresión de p53, MIB-1 y PECAM-1 en el pronóstico del carcinoma urotelial de la pelvis renal

Actas Urológicas Españolas - Tập 38 - Trang 506-514 - 2014
A. García-Tello1, J.C. Angulo1, G. Andrés1, F. Ramón de Fata1, M. Sánchez-Chapado2, J.I. López3
1Servicio de Urología, Hospital Universitario de Getafe, Departamento Clínico, Facultad de Ciencias Biomédicas, Universidad Europea de Madrid, Madrid, España
2Servicio de Urología, Hospital Universitario Príncipe de Asturias, Departamento de Cirugía, Facultad de Medicina, Universidad de Alcalá, Madrid, España
3Servicio de Anatomía Patológica, Hospital Universitario de Cruces, Universidad del País Vasco (UPV/EHU), Barakaldo, España

Tài liệu tham khảo

Siegel, 2014, Cancer statistics, 2014, CA Cancer J Clin, 64, 9, 10.3322/caac.21208

Das, 1990, Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival, Cancer, 66, 1919, 10.1002/1097-0142(19901101)66:9<1919::AID-CNCR2820660911>3.0.CO;2-Z

Gupta, 2008, Neoplasms of the upper urinary tract: A review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting, Adv Anat Pathol, 15, 127, 10.1097/PAP.0b013e31817145a9

Akaza, 1987, Clinical evaluation of urothelial tumors of the renal pelvis and ureter based on a new classification system, Cancer, 59, 1369, 10.1002/1097-0142(19870401)59:7<1369::AID-CNCR2820590724>3.0.CO;2-A

Huben, 1988, Tumor grade and stage as prognostic variables in upper tract urothelial tumors, Cancer, 62, 2016, 10.1002/1097-0142(19881101)62:9<2016::AID-CNCR2820620924>3.0.CO;2-G

Margulis, 2009, Outcomes of radical nephroureterectomy: A series from the upper tract urothelial carcinoma collaboration, Cancer, 115, 1224, 10.1002/cncr.24135

Zhang, 2001, Evaluation of cell proliferation, apoptosis, and angiogenesis in transitional cell carcinoma of the renal pelvis and ureter, Urology, 57, 981, 10.1016/S0090-4295(00)01130-4

Kamijima, 2005, The prognostic value of p53. Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter, Int J Urol, 12, 941, 10.1111/j.1442-2042.2005.01159.x

Scarpini, 2012, Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract, Urol Oncol, 30, 182, 10.1016/j.urolonc.2009.12.003

Krabbe, 2014, Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma, J Urol, 191, 28, 10.1016/j.juro.2013.07.012

Vogelstein, 1992, p53 function and dysfunction, Cell, 70, 523, 10.1016/0092-8674(92)90421-8

Sarkis, 1993, Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression, J Natl Cancer Inst, 85, 53, 10.1093/jnci/85.1.53

Lipponen, 1993, Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value, Int J Cancer, 53, 365, 10.1002/ijc.2910530304

Uchida, 1995, p53 mutations and prognosis in bladder tumors, J Urol, 153, 1097, 10.1016/S0022-5347(01)67517-7

Nakanishi, 1996, Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract, Hum Pathol, 27, 1336, 10.1016/S0046-8177(96)90347-0

Furihata, 1996, Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia, J Pathol, 178, 133, 10.1002/(SICI)1096-9896(199602)178:2<133::AID-PATH455>3.0.CO;2-F

Rey, 1997, Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival, Cancer, 79, 2178, 10.1002/(SICI)1097-0142(19970601)79:11<2178::AID-CNCR16>3.0.CO;2-T

Hashimoto, 2000, Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter, Int J Urol, 7, 457, 10.1046/j.1442-2042.2000.00230.x

Key, 1993, New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections, J Clin Pathol, 46, 1080, 10.1136/jcp.46.12.1080

Brown, 2002, Ki67 protein: The immaculate deception?, Histopathology, 40, 2, 10.1046/j.1365-2559.2002.01343.x

Margulis, 2006, Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease, Clin Cancer Res, 12, 7369, 10.1158/1078-0432.CCR-06-1472

Margulis, 2009, Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer, J Natl Cancer Inst, 101, 114, 10.1093/jnci/djn451

Newman, 1990, PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily, Science, 247, 1219, 10.1126/science.1690453

Albelda, 1991, Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule, J Cell Biol, 114, 1059, 10.1083/jcb.114.5.1059

Tang, 1993, Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium, J Biol Chem, 268, 22883, 10.1016/S0021-9258(18)41609-2

Jackson, 1997, J Biol Chem, 272, 6986, 10.1074/jbc.272.11.6986

Hall, 1998, Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients, Urology, 52, 594, 10.1016/S0090-4295(98)00295-7

Lughezzani, 2009, Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: A population-based study of 2,299 patients, Eur J Cancer, 45, 3291, 10.1016/j.ejca.2009.06.016

Akdogan, 2006, Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma, J Urol, 176, 48, 10.1016/S0022-5347(06)00511-8

Lughezzani, 2012, Prognostic factors in upper urinary tract urothelial carcinomas: A comprehensive review of the current literature, Eur Urol, 62, 100, 10.1016/j.eururo.2012.02.030

Cha, 2012, Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma, Eur Urol, 61, 818, 10.1016/j.eururo.2012.01.021

Remzi, 2009, Tumour architecture is an independent predictor of outcomes after nephroureterectomy: A multi-institutional analysis of 1,363 patients, BJU Int, 103, 307, 10.1111/j.1464-410X.2008.08003.x

Fritsche, 2012, Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma, Urol Oncol, 30, 666, 10.1016/j.urolonc.2010.07.010

Perez-Montiel, 2006, High-grade urothelial carcinoma of the renal pelvis: Clinicopathologic study of 108 cases with emphasis on unusual morphologic variants, Mod Pathol, 19, 494, 10.1038/modpathol.3800559

Xylinas, 2012, Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy, Eur Urol, 62, e25, 10.1016/j.eururo.2012.04.023

Sjödahl, 2013, Toward a molecular pathologic classification of urothelial carcinoma, Am J Pathol, 183, 681, 10.1016/j.ajpath.2013.05.013

Li, 2009, The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy, J Urol, 182, 451, 10.1016/j.juro.2009.04.026

Li, 2008, Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients, Eur Urol, 54, 1127, 10.1016/j.eururo.2008.01.054

Lin, 2008, The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0), J Urol, 180, 879, 10.1016/j.juro.2008.05.022

Kikuchi, 2009, Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma, J Clin Oncol, 27, 612, 10.1200/JCO.2008.17.2361

Novara, 2010, Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: An international validation study, Eur Urol, 57, 1064, 10.1016/j.eururo.2009.12.029

Bolenz, 2009, Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis, BJU Int, 103, 1040, 10.1111/j.1464-410X.2008.08135.x

Simone, 2009, Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma, BJU Int, 103, 1052, 10.1111/j.1464-410X.2008.08134.x

Langner, 2006, Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract, J Urol, 176, 910, 10.1016/j.juro.2006.04.019

Seitz, 2010, Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study, J Urol, 184, 1895, 10.1016/j.juro.2010.06.106

Park, 2004, The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract, J Urol, 171, 621, 10.1097/01.ju.0000107767.56680.f7

Yates, 2012, Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: Proposal and multi-institutional validation of a post-operative nomogram, Br J Cancer, 106, 1083, 10.1038/bjc.2012.64

Rouprêt, 2013, Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: Development of an optimized postoperative nomogram using decision curve analysis, J Urol, 189, 1662, 10.1016/j.juro.2012.10.057

Ku, 2013, External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma, Br J Cancer, 109, 1130, 10.1038/bjc.2013.462

Seisen, 2014, Post-operative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localized and/or locally advanced upper tract urothelial carcinoma without metastasis, BJU Int, 10.1111/bju.12631

Hellenthal, 2009, Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: Results from the upper tract urothelial carcinoma collaboration, J Urol, 182, 900, 10.1016/j.juro.2009.05.011

Raman, 2014, High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy, Urol Oncol, 32, 47, 10.1016/j.urolonc.2013.06.015

Krabbe, 2013, Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract-is there evidence for discordant biology?, J Urol

Zigeuner, 2004, Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma, Urology, 63, 1079, 10.1016/j.urology.2004.01.009

Fromont, 2005, Tissue microarray analysis of the prognostic value of E-cadherin. Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma, Eur Urol, 48, 764, 10.1016/j.eururo.2005.07.005

Ku, 2013, The role of p53 on survival of upper urinary tract urothelial carcinoma: A systematic review and meta-analysis, Clin Genitourin Cancer, 11, 221, 10.1016/j.clgc.2012.12.009

Kamai, 2000, Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter, BJU Int, 86, 14, 10.1046/j.1464-410x.2000.00726.x

Jeon, 2010, Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma, Urology, 76, 513, 10.1016/j.urology.2010.03.070

Baderca, 2005, Angiogenesis in urothelial tumors of the upper urinary tract, Rom J Morphol Embryol, 46, 263

Thông tin
Thông tin xuất bản

Actas Urológicas Españolas

Tập 38

506-514

Thông tin tác giả